The CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering.

The companies BridgeBio, Erasca, Chai Discovery, and MeiraGTx bagged the biggest biotech funding rounds overall in July 2026.

About half of people with gout don't have treatments that work. Meet the new gout drugs racing through trials to reach them.

We look at some of the top companies that are investigating CAR-T therapies in clinical trials for autoimmune diseases.

Delve into what Merck has planned for the future of its pipeline as Keytruda's patent is getting closer to expiry.

The top biotech deals of July 2026 were over small molecules, cell therapies, antibodies, RNA therapeutics, vaccines, and AI.

With one of the most densely concentrated life sciences and biotech ecosystems in Europe, the Netherlands is home to numerous biotech and pharmaceutical companies, and also happens to be the ...

The biopharma industry has seen its fair share of clinical and financial failures. When biotechs face setbacks, their stock values plummet and they lack the funds to develop new medicines, restructure ...

The recent release of the latest BioRegion Report brought with it some very welcome news for Catalonia, as the autonomous northeastern region of Spain consolidated its place as one of the country’s ...

Altesa BioSciences, founded in 2020 and based in College Park, launched with a $35 million series A round. The Georgia company is focused on developing antiviral drugs particularly targeting ...

California-based Cargo Therapeutics has had a rough year with its CAR-T cell therapy firicabtagene autoleucel being discontinued after patients experienced toxic side effects in the clinic. The ...

Antibiotic-resistant superbugs cause many deaths around the world each year, but effective new antibiotics are thin on the ground. Could bacteria-eating phage viruses be the answer to this problem?